InspireMD, Inc. Operating Income Loss

• InspireMD, Inc. showed a decrease of -48.1% in Operating Income Loss from 2024 to 2025.
• This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), InspireMD, Inc.'s Operating Income Loss has declined by 1,726.1%.
• Historical annual values: Fiscal year 2025: -$49.61 million | Fiscal year 2024: -$33.50 million | Fiscal year 2023: -$21.14 million | Fiscal year 2022: -$18.71 million | Fiscal year 2021: -$14.72 million | Fiscal year 2020: -$10.38 million | Fiscal year 2019: -$9.82 million | Fiscal year 2018: -$7.61 million | Fiscal year 2017: -$8.23 million | Fiscal year 2016: -$7.65 million | Fiscal year 2015: -$14.49 million | Fiscal year 2014: -$23.70 million | Fiscal year 2013: -$15.07 million | Fiscal year 2012: -$17.55 million | Fiscal year 2011: -$13.73 million | Fiscal year 2010: -$3.22 million | Fiscal year 2009: -$2.72 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026